课题基金 / 基金详情

PROTEIN UNFOLDING/REFOLDING DURING MITOCHONDRIAL IMPORT

PROTEIN UNFOLDING/REFOLDING DURING MITOCHONDRIAL IMPORT
线粒体导入过程中蛋白质的解折叠/重折叠
批准号:
6972152
负责人:
JOHN R ENGEN
金额:
$13.77万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-05 至 2005-06-30

项目摘要

项目成果

JOHN R ENGEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Proteins must unfold prior to transport into most organelles. In the mitochondrial import mechanism, molecular chaperones begin the unfolding process for most proteins and then pass the partially denatured protein to the import machinery in the mitochondrial membrane. It is unclear if and to what extent proteins in the transport machinery of the mitochondrial outer membrane (TOM) posses intrinsic unfolding activity that they use to help unfold importing proteins. If TOM proteins do contain unfolding activity, it would mean that mitochondria themselves participate in unfolding during import rather than leaving the entire job to the cytoplasmic chaperones. To determine if TOMs posses unfolding activity, two members of the human TOM complex (Tom20 and Tom22) will be tested for their ability to unfold the test protein dihydrofolate reductase (DHFR). Hydrogen exchange mass spectrometry, a method very sensitive to changes in protein structure and unfolding, will be used to compare the deuterium exchange into DHFR alone versus DHFR incubated with either Tom20 or Tom22. The results are expected to demonstrate how much unfolding activity Tom20 and Tom22 have, the magnitude of resulting unfolding and the location of the unfolding in DHFR. With such data, the unfolding that occurs at several individual steps in the transport process will be elucidated, information that is key to understanding the fundamental biological process of unfolding during import.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
  • 批准号:
    10304896
  • 项目类别:
  • 资助金额:
    $47.13万
  • 财政年份:
    2019
  • 负责人:
    JOHN R ENGEN
  • 依托单位:
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
  • 批准号:
    9895250
  • 项目类别:
  • 资助金额:
    $54.45万
  • 财政年份:
    2019
  • 负责人:
    JOHN R ENGEN
  • 依托单位:
Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
  • 批准号:
    10062486
  • 项目类别:
  • 资助金额:
    $48.09万
  • 财政年份:
    2019
  • 负责人:
    JOHN R ENGEN
  • 依托单位:
Extending the applications of hydrogen exchange mass spectrometry
  • 批准号:
    8928002
  • 项目类别:
  • 资助金额:
    $29.55万
  • 财政年份:
    2012
  • 负责人:
    JOHN R ENGEN
  • 依托单位:
国内基金
海外基金
皮层蛋白羧基端功能的酪氨酸磷酸化调节机制及其在肿瘤细胞运动中的作用研究
  • 批准号:
    30771126
  • 项目类别:
    面上项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2007
  • 负责人:
    朱建伟
  • 依托单位: